Related Experiment Video
Updated: Aug 9, 2026
11:14
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
[Configuration in solution and activity mechanism studies on the anticancer Fe(II)-pingyangmycin (PYM) complex]
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|May 23, 2002
Summary
The active Fe(II)-Pingyangmycin (PYM) complex exhibits unique structural diversity compared to inactive Cu(II)-PYM and Fe(III)-PYM complexes. This distinct micro-configuration is crucial for understanding the anticancer activity mechanism of Fe(II)-PYM.
Area of Science:
- Coordination chemistry
- Medicinal inorganic chemistry
- Biophysical chemistry
Context:
- Pingyangmycin (PYM) is an anticancer drug whose efficacy is influenced by metal ion coordination.
- Understanding the solution-state structure of metal-PYM complexes is key to elucidating their mechanism of action.
- Paramagnetic ion probe techniques offer insights into the micro-configuration of metal complexes.
Purpose:
- To investigate the solution-state micro-configuration of the active Fe(II)-PYM complex.
- To compare the structural parameters of Fe(II)-PYM with inactive Cu(II)-PYM and Fe(III)-PYM complexes.
- To correlate structural diversity with the anticancer activity mechanism of Fe(II)-PYM.
Summary:
- Proton Magnetic Resonance (PMR) and paramagnetic ion probe principles were used to study Fe(II)-PYM, Fe(III)-PYM, and Cu(II)-PYM complexes in D2O.
- Distinct coordination distances between the central metal ion and PYM ligand protons were determined for each complex.
- Fe(II)-PYM displayed unique structural parameters, with shorter metal-ligand distances (4.91–8.85 Å) compared to Fe(III)-PYM (7.0–15.0 Å for most protons).
Impact:
- Reveals a structure-activity relationship for Fe(II)-PYM anticancer complexes.
- Provides a basis for designing novel metallodrugs with enhanced therapeutic potential.
- Advances the understanding of metal ion coordination in drug delivery and action.
